chlormadinone acetate has been researched along with Polycystic Ovary Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Luisi, S; Meczekalski, B; Petraglia, F; Podfigurna, A | 1 |
| Abbas, AM; Abdel-Maboud, M; Abdelghany, MF; Bahbah, EI; El-Din, AA; Elgebaly, A; Gadelkarim, M; Ismail, A; Menshawy, A; Samy, A | 1 |
| Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
| Agnello, C; Caruso, S; Cianci, A; Romano, M; Rugolo, S | 1 |
| Bompiani, A; Campagna, G; Guido, M; Lanzone, A; Ricciardi, L; Romualdi, D | 1 |
| Etzi, R; Guerriero, S; Lello, S; Marotto, MF; Melis, GB; Orrù, M; Pani, F; Paoletti, AM; Pilloni, M; Sorge, R; Uras, R; Zedda, P | 1 |
| Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
| de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS | 1 |
| Belo, VA; Ferriani, RA; França, JB; Gomes, VA; Jacob-Ferreira, AL; Soares, GM; Tanus-Santos, JE; Vieira, CS | 1 |
| Carranza-Lira, S; Magaña-Padilla, NR | 1 |
| Baiza, MR; Carranza-Lira, S; García-Hernández, E; Morán, C | 1 |
1 review(s) available for chlormadinone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Topics: Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Humans; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone | 2019 |
5 trial(s) available for chlormadinone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.
Topics: Adolescent; Adult; Blood Glucose; Chlormadinone Acetate; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Young Adult | 2010 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation | 2012 |
[Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment ].
Topics: Adult; Chlormadinone Acetate; Cholesterol; Desogestrel; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Ovarian Follicle; Polycystic Ovary Syndrome; Progesterone Congeners; Severity of Illness Index; Treatment Outcome; Triglycerides; Ultrasonography | 2002 |
5 other study(ies) available for chlormadinone acetate and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).
Topics: Adult; Androstenes; Blood Glucose; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2020 |
Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Chlormadinone Acetate; Coitus; Contraceptives, Oral, Synthetic; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Self Concept; Severity of Illness Index; Sexual Behavior; Surveys and Questionnaires; Time Factors; Young Adult | 2009 |
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgens; Anthropometry; Body Composition; Chlormadinone Acetate; Contraceptives, Oral, Combined; Electric Impedance; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Polycystic Ovary Syndrome; Young Adult | 2010 |
Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Anthropometry; Brazil; Chlormadinone Acetate; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Polycystic Ovary Syndrome; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Young Adult | 2012 |
The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome.
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Chlormadinone Acetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone Congeners; Time Factors | 1996 |